«SGLT2i pharmacological treatment in type 2 diabetes mellitus control and its underlying obesity» (2024) Revista Portuguesa de Medicina Geral e Familiar, 40(2), pp. 148–56. doi:10.32385/rpmgf.v40i2.13647.